Episode 7: The Next Pandemic After Immunity
Given the events that have unfolded, how might we prepare for the next pandemic? What lessons have we learned from the COVID-19 pandemic and what insurance and risk mitigation policies should governments put in place?
Today on our final episode we examine the next pandemic after immunity. Join us as we talk with Dr. Allan Detsky, physician and professor of Health Policy Management and Evaluation at the University of Toronto and former Physician-In-Chief at Mount Sinai Hospital; and Dr. Charlotte Hammer, a field epidemiologist at the European Centre for Disease Prevention and Control, and research affiliate with the University of Cambridge Centre for the Study of Existential Risk.
The introductory statement starts at 0:40
Allan Detsky’s interview starts at 4:09 (Interview Transcript)
Charlotte Hammer’s interview starts 35:22 (Interview Transcript)
Out intermission music comes courtesy of Human Music. The track is “Tea Leaves” from their 2018 self-titled release. Be sure to check out more tunes at their Bandcamp: https://humanmusic.bandcamp.com
If you have any thoughts or comments on the episode, please email us at email@example.com
A big thanks to Jared McKetiak, Neil Kraemer, Theo Blumrich, Lindsey Nadon, Jonah Kotzer, and Glen and Janine for their help with the series; all of our guests for providing their thoughts on the post-COVID-19 world; and you the listener for tuning in these last few weeks!
Dr. Allan Detsky
Dr. Detsky is a physician and professor of Health Policy Management and Evaluation at the University of Toronto. A Member of the Order of Canada, he was the Physician-In-Chief at Mount Sinai Hospital in Toronto during the SARS outbreak of 2003.
Dr. Charlotte Hammer
Dr. Charlotte Hammer is an emergency public health and infectious diseases epidemiologist. She is a fellow with the European Programme for Intervention Epidemiology Training at the European Centre for Disease Prevention and Control, as well as a research affiliate with the University of Cambridge’s Centre for the Study of Existential Risk. Her speciality is in contextual factors that drive outbreak risk, particularly of emerging zoonotic diseases.